<?xml version="1.0"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/"><rdf:Description rdf:about="https://dirros.openscience.si/IzpisGradiva.php?id=27900"><dc:title>Incidence of major adverse cardiovascular events in patients with rheumatoid arthritis treated with Janus kinase inhibitors compared to biologic disease-modifying antirheumatic drugs</dc:title><dc:creator>Aymon,	Romain	(Avtor)
	</dc:creator><dc:creator>Mongin,	Denis	(Avtor)
	</dc:creator><dc:creator>Guemara,	Romain	(Avtor)
	</dc:creator><dc:creator>Salis,	Zubeyir	(Avtor)
	</dc:creator><dc:creator>Askling,	Johan	(Avtor)
	</dc:creator><dc:creator>Choquette,	Denis	(Avtor)
	</dc:creator><dc:creator>Codreanu,	Catalin	(Avtor)
	</dc:creator><dc:creator>Di Giuseppe,	Daniela	(Avtor)
	</dc:creator><dc:creator>Flouri,	Irini	(Avtor)
	</dc:creator><dc:creator>Huschek,	Doreen	(Avtor)
	</dc:creator><dc:creator>Rotar,	Žiga	(Avtor)
	</dc:creator><dc:subject>adverse cardiovascular events</dc:subject><dc:subject>rheumatoid arthritis</dc:subject><dc:subject>patients</dc:subject><dc:subject>Janus kinase inhibitors</dc:subject><dc:subject>biologic disease-modifying antirheumatic drugs</dc:subject><dc:subject>"JAK-pot" study</dc:subject><dc:date>2025</dc:date><dc:date>2026-02-27 09:47:35</dc:date><dc:type>Neznano</dc:type><dc:identifier>27900</dc:identifier><dc:language>sl</dc:language></rdf:Description></rdf:RDF>
